Abstract: Lugdunin, anovel thiazolidine cyclopeptide,exhibits micromolar activity against methicillin-resistant Staphylococcus aureus (MRSA). Fors tructure-activity relationship (SAR) studies,synthetic analogues obtained from alanine and stereo scanning as well as peptides with modified thiazolidine rings were tested for antimicrobial activity.T he thiazolidine ring and the alternating d-a nd l-amino acid backbone are essential. Notably,t he non-natural enantiomer displays equal activity,t hus indicating the absence of ac hiral target. The antibacterial activity strongly correlates with dissipation of the membrane potential in S. aureus.L ugdunin equalizes pH gradients in artificial membrane vesicles,t herebym aintaining membrane integrity,w hich demonstrates that proton translocation is the mode of action (MoA). The incorporation of extra tryptophan or propargyl moieties further expands the diversity of this class of thiazolidine cyclopeptides.
Infectious diseases caused by antibiotic-resistant bacteria are an increasing health problem worldwide,e specially the fast dissemination of MRSA. [1] As novel antibiotic entities have rarely been discovered in the last decade,weh ave an urgent need to find new structures.N umerous peptides such as daptomycin add to the great structural diversity of pharmaceutical agents.M odifications of peptide antibiotics are achieved by insertion of particular moieties,f or example, double bonds or heterocycles,i nto the backbone structure. Thecyclopeptide callyaerin and one of its analogues differ by ad ouble bond, which confers constraints that correlate directly with their activity. [2] Notably,five-and six-membered carbocycles within the backbone mimic conformationally restricted b-and g-amino acids. [3] Naturally occurring heterocycles also determine the structural flexibility of peptide macrocycles. [4] Interestingly,t hiazolidine rings have not been reported as cyclopeptide components so far. During ascreening approach for antibiotics using human bacterial nasal isolates, [5] lugdunin (1,S cheme 1) was discovered. [6] 1 is an onribosomal cyclic peptide produced by Staphylococcus lugdunensis and features at hiazolidine ring as part of the backbone. 1 shows potent antimicrobial activity against pathogenic bacteria such as MRSA with am inimum inhibitory concentration (MIC) of 3.1 mgmL À1 (3.9 mm). Furthermore, 1 mediates bactericidal effects when applied to mice after skin infection by S. aureus. However,the mode of action (MoA) of 1 has remained elusive.
We previously established the synthesis of 1 for the structural proof of natural lugdunin. [6] Now we present ac omprehensive structure-activity relationship (SAR) study to identify the essential motifs of 1 for its antimicrobial activity.D erivatives of 1 were produced by solid-phase peptide synthesis (SPPS) on an aldehyde-generating resin. After assembly of the peptide chain and deprotection of the side chains,t he linear aldehyde was released from the resin. Subsequent intramolecular heterocyclization of the C-terminal aldehyde and the N-terminal cysteine afforded the macrocycle 1 through in situ thiazolidine formation. [7] The thiazolidine,a nd thus 1,e xists in two interconverting and, therefore,i nseparable epimeric forms (Scheme 1). Thep oor coupling of consecutive valine residues (Val 5 ,V al 6 )w as addressed by peptide elongation in acetonitrile (see Figure S1 in the Supporting Information). Theo ptimized strategy provided access to many peptides.
All the peptides were tested as crude products for activity against the MRSA strain USA300 LAC(hereafter:USA300, Table 1 ). During cleavage,the aldehyde a-carbon atom of the valine residue at position 7( Va l 7 ,A la 7 in 8)o ft he peptides partially racemized, thereby leading to mixtures of l-a nd dvaline or -alanine adjacent to the thiazolidine ring (see Scheme S1 and Figure S2 in the Supporting Information). Crude peptides with significant activity (MIC 50 mgmL À1 ) were purified to determine the exact MIC.W es uggest terming the new class of lugdunins fibupeptides (lat. fibula, clasp) to define macrocyclic peptides with at hiazolidine moiety as an "ornament clasp".
Theimportance of individual amino acids for the activity of 1 was revealed by an alanine scan, [8] which yielded fibupeptides 2-8.E ach amino acid of 1 was successively replaced by alanine with the same stereoconfiguration. Antimicrobially inactive peptide 2 neither carries at hiazolidine nor is cyclic because of the lack of cysteine.M ass spectrometry analysis of 2 showed the formation of an aldehyde-methanol adduct ([M + MeOH] + , m/z 801.5232, 0.12 Dppm). This is in agreement with the finding of Enck et al. that the precursor aldehyde of tyrocidine Ad id not spontaneously cyclize to the imine. [9] Consequently,cysteine and, hence,the thiazolidine ring is essential. Active alanine peptides 3, 6, 7,a nd 8 showed MIC values of 12.5 mgmL À1 (16.6 mm)t o2 5 mgmL À1 (33.1 mm), which is af our-t oe ightfold reduction in the antimicrobial activity.T he most pronounced impact on antibiotic efficacy was detected for the exchange of Tr p 3 (4)a nd Leu 4 (5)f or alanine.B oth derivatives showed MIC values ! 100 mgmL
À1
and were regarded as inactive.T herefore,t ryptophan and Scheme 1. Solid-phase aldehyde peptide synthesis of 1. 
[a] MRSA USA300 LAC (MIC in mgmL À1 (mm). For S. aureus NCTC8325 MICs, see Table S3 ). Single-letter codes for amino acids, brackets indicate cyclic structure (cyclization via thiazolidine), cycl. indicates cyclization via the peptide bond, underlined letters represent d-amino
+ by ESI-MS, Ala = alanine, Pro = proline, Trp = tryptophan,P ra = propargylglycine.
leucine are crucial for the antibacterial activity,w hereas valine versus alanine exchanges are well-tolerated. However, the different activities of 3, 6, 7,a nd 8 imply ad istinct relevance of each valine.
Theimportance of the thiazolidine ring was investigated, starting with the linear lugdunin peptide 9 ( Figure 1 ). Intramolecular cyclization of 9 yielded homodetic analogue 10 in which the ring is composed exclusively of normal peptide bonds.B oth peptides were inactive against USA300. In addition, the role of the thiazolidine NH proton was addressed by replacing it by at ertiary amine through methylation (11)a nd acetylation (12) . 11 and 12 are inactive as antibacterial agents,thus demonstrating the indispensability of the secondary amine of the thiazolidine ring. We speculate that the basicity of the thiazolidine amine or its three-dimensional structure are responsible for the bioactivity of 1.I nactive 13 was prepared with homocysteine to expand the heterocycle by an additional methylene group. Thes ix-membered 1,3-thiazinane affects the structure of 1 adversely in terms of activity,e ven though it contains as econdary amine.S ince the thiazolidine resembles an unusual 2-connected thioproline,w es ynthesized the proline-containing homodetic 14,which was inactive.Thus,both, the thiazolidine ring and its secondary amine are essential for the antimicrobial activity of 1.
Thei ntriguing d-,l-architecture of 1 prompted us to conduct as tereo scan, while retaining the sequence and hydrophobic character of 1.O ne amino acid at at ime was incorporated as its enantiomer (15) (16) (17) (18) (19) (20) (21) . All the diastereomers were ineffective against USA300, which demonstrates that any inversion of astereogenic center dramatically affects the antimicrobial potency. To clarify whether the inversion of the absolute configuration of 1 also has such an impact on activity, we synthesized its enantiomer 22.R emarkably, 22 showed identical antibiotic activity as 1.This situation has been rarely discussed for natural products,f or example,f or the antiviral feglymycin [8] or the antibiotic lysocin E. [10] Theinsignificance of the absolute configuration of 1 suggests that the MoA does not depend on as tereospecific receptor-ligand interaction but could involve the recognition of achiral small molecules or ions. [10] Together,t hese SAR studies revealed that an unsubstituted thiazolidine,t ryptophan, leucine,a nd an alternating amino acid stereoconfiguration are essential structural motifs of 1.T ryptophan and leucine are abundant in peptides that interact with bacterial cell membranes such as synthetic poly-(Trp-Leu)-octapeptides. [11] Then ecessity of tryptophan and leucine and the decrease in the activity of the less hydrophobic alanine fibupeptides 3, 6, 7,and 8 pointed towards an interaction of 1 with the hydrophobic region of bacterial membranes.
Ad ouble tryptophan-containing fibupeptide (23)w as designed to intensify the presumed interaction with the bacterial membrane. d-Tryptophan was incorporated (Trp 6 ) within the nonpolar flank (dLeu 4 -lVa l 5 -dVa l 6 -lVa l 7 )o f1. Fibupeptide 23 showed atwofold increased activity.Ascould be deduced from the alanine scan, position 2shows tolerance for side-chain modification while retaining activity.I ncorporation of d-propargylglycine (Pra) at this position in 23 resulted in active derivative 24. 24 is suitable for 1,3-dipolar cycloaddition to enable the production of further analogues, preferably with activity against Gram-negative bacteria. [12] With the knowledge that the enantiomer (22, Figure 2 ) shows activity identical to 1,wesuspected that 1 might move achiral molecules or ions across lipid membranes.T his concurs with our previous observation that bacterial cells exposed to 1 stopped incorporating radioactive DNA, RNA, protein, and cell-wall precursors. [6] Thus,t he influence of the active fibupeptides 1, 3, 22,a nd 23 on the transmembrane potential of S. aureus NCTC8325 was compared to that of the less active or inactive 5, 11,and 21.Whenentering the cell, the green fluorescence of the dye DiOC 2 (3) shifts towards ar ed emission because of as elf-association that depends on membrane potential. [13] All the tested peptides affected the transmembrane potential of S. aureus NCTC8325, in full correlation with their MIC values,a nd in ac oncentration-dependent manner (Figure 3 , see also Figure S11 and Table S3 in the Supporting Information). Partial membrane depolarization occurred at concentrations slightly below the MIC (0.125-0.5 MIC), while inactive 11 showed no effect. This is in accordance with the parallel cessation of all biosynthetic pathways and indicates aMoA involving impairment of membrane integrity or ion leakage/transport.
Remarkably, 1 does not tolerate amino acids with polar (Ser,T hr) or protonated (Lys) side chains without losing bioactivity-in contrast to common peptides that disrupt the membrane potential such as gramicidin A.
To analyze the effects on bacterial membranes,wetreated S. aureus with 1 and subsequently added amixture of the dyes Syto9 and propidium iodide (PI) to the cells as an indicator for pore formation. Thered-fluorescent PI can only cross the cytoplasmic membrane through large pores or lesions.T reatment with 1 up to ac oncentration of 30 mgmL À1 (10 MIC) did not allow for PI entry into the S. aureus cells,w hile nisin led to astrong influx of the dye because of its ability to form large pores ( Figure 4A) .
We further employed unilamellar vesicles composed of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) as amembrane model system to assess the activity of 1.The use of artificial lipid bilayers enables the characterization of membrane activity independent of other factors such as proteins.W ei nvestigated first whether 1 impairs vesicle integrity. [14] Thea bility of 1 to induce release of the fluorescent dye carboxyfluorescein (CF) was compared to that of the cyclic decapeptide gramicidin S( 25), which can destabilize membranes. [15] Thedye is entrapped in vesicles in as elf-quenching concentration (100 mm)a nd leakage results in an increase in fluorescence.I nc ontrast to 25, 1 induced only very slow leakage of the dye even at high concentrations ( Figure 4B ). This result supports the notion that 1 does not destabilize the membrane,b ut rather acts by translocating ions.
We investigated the ability of 1 to transport protons by using vesicles filled with the pH-sensitive fluorescent dye pyranine (HPTS). [16] ApHgradient was established across the lipid bilayer and proton transport was observed as achange in fluorescence.A sp roton translocation across am embrane induces at ransmembrane potential that prevents further transport, the change in the internal pH value is also dependent on charge equilibration and, therefore,t ransport of further ions.Acontrol experiment with the protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and the potassium ionophore valinomycin showed that both ions have to be transported to explain rapid pH equilibration (see Figure S12 in the Supporting Information). Figure 5s hows that 1 causes rapid proton translocation at concentrations as low as 50 nm (peptide to lipid ratio (P/L) 1:1000) irrespective of the direction of the gradient. To exclude dye leakage, pyranine fluorescence was quenched outside the vesicles in ac ontrol experiment (see Figure S12 in the Supporting Information).
In this pH assay, 1 demonstrated as ignificantly higher proton translocation capability than 25,w hereas antimicrobially inactive 11 showed greatly reduced proton transport ( Figure 5C ). This finding suggests av ital role of the thiazolidine moiety in proton translocation and is in agreement with the membrane depolarization data.
In summary,weestablished an optimized synthesis of 1 to provide access to manifold analogues.B yS AR studies,w e revealed the essential motifs for antimicrobial activity, notably,the alternation of d-and l-amino acids,the presence of tryptophan and leucine,a sw ell as the N-unsubstituted thiazolidine ring. Thei dentical activity of the enantiomer 22 suggested that chiral recognition was not relevant for the MoA of 1.Additionally, 1 and its analogues illustrate astrong correlation between membrane depolarization and MIC values with S. aureus cells.F urthermore, 1 did not induce large pores in either S. aureus cells or POPC vesicles and acts through proton translocation in synthetic membrane vesicles. In addition, the twofold more active 23 (Trp 6 )v erified these insights. Thea ctive analogue 24 with ap ropargyl function paves the way for the production of analogues with optimized bioactivity or fluorescent properties,which will contribute to elucidating the mechanistic interaction between 1 and MRSA on the molecular level. Theexact role of the vital thiazolidine ring is the focus of current investigations along with the question of whether 1 translocates protons as amobile carrier or by channel formation.
